Articles dans des revues avec comité de lecture (112)
  1. 104. Depondt, C. (2006). The potential of pharmacogenetics in the treatment of epilepsy. European journal of paediatric neurology, 10(2), 57-65. doi:10.1016/j.ejpn.2005.11.009
  2. 105. Depondt, C., Yuen, A. W. C., Bell, G., Mitchell, T., Koepp, M. J., Duncan, J. S., & Sander, J. W. (2006). The long term retention of levetiracetam in a large cohort of patients with epilepsy. Journal of neurology, neurosurgery and psychiatry, 77(1), 101-103. doi:10.1136/jnnp.2005.064626
  3. 106. Cavalleri, G. L., Lynch, J. M., Depondt, C., Burley, M.-W., Wood, N. W., Sisodiya, S. M., & Goldstein, D. B. (2005). Failure to replicate previously reported genetic associations with sporadic temporal lobe epilepsy: where to from here? Brain, 128(Pt 8), 1832-1840. doi:10.1093/brain/awh524
  4. 107. Tate, S. K., Depondt, C., Sisodiya, S. M., Cavalleri, G. L., Schorge, S., Soranzo, N., Thom, M., Sen, A., Shorvon, S., Sander, J. W., Wood, N. W., & Goldstein, D. B. (2005). Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin. Proceedings of the National Academy of Sciences of the United States of America, 102(15), 5507-5512. doi:10.1073/pnas.0407346102
  5. 108. Depondt, C., Cock, H. R., Healy, D. G., Burley, M. W., Weinshenker, D., Wood, N. W., Goldstein, D. B., & Sisodiya, S. M. (2004). The -1021C->T DBH gene variant is not associated with epilepsy or antiepileptic drug response. Neurology, 63(8), 1497-1499.
  6. 109. Claes, L., Audenaert, D., Deprez, L., Van Paesschen, W., Depondt, C., Goossens, D., Del-Favero, J., Van Broeckhoven, C., & de Jonghe, P. (2004). Novel locus on chromosome 12q22-q23.3 responsible for familial temporal lobe epilepsy associated with febrile seizures. Journal of medical genetics, 41(9), 710-714. doi:10.1136/jmg.2004.019257
  7. 110. Soranzo, N., Cavalleri, G. L., Weale, M. E., Wood, N. W., Depondt, C., Marguerie, R., Sisodiya, S. M., & Goldstein, D. B. (2004). Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene. Genome research, 14(7), 1333-1344. doi:10.1101/gr.1965304
  8. 111. Weale, M. E., Depondt, C., Macdonald, S. J., Smith, A., Lai, P. S., Shorvon, S., Wood, N. W., & Goldstein, D. B. (2003). Selection and evaluation of tagging SNPs in the neuronal-sodium-channel gene SCN1A: implications for linkage-disequilibrium gene mapping. American journal of human genetics, 73(3), 551-565. doi:10.1086/378098
  9. 112. Depondt, C., Van Paesschen, W., Matthijs, G., Legius, E., Martens, K., Demaerel, P., & Wilms, G. (2002). Familial temporal lobe epilepsy with febrile seizures. Neurology, 58(9), 1429-1433.
    10.   Communications publiées lors de congrès ou colloques nationaux et internationaux (5)
  10. 1. Naeije, G., Gaspard, N., Depondt, C., Pepersack, T., & Legros, B. (2012). Acute confusional state of unknown cause in the elderly: a study with continuous EEG monitoring. American Clinical Neurophysiology Society (ACNS) Annual Meeting and Courses (February 7-12, 2012: San Antonio, Texas)
  11. 2. Depondt, C. (2008). Progress in pharmacogenetics. Acta Neurologica Belgica Belgian Society of Pediatric Neurology(April 2008: Leuven, Belgium)
  12. 3. Depondt, C. (2006). Pharmacodynamic pharmacogenomics as applied to epilepsy. In Epilepsia: Vol. 47 (pp. 1-272) Wiley.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 Suivant >>